Drug recall · May 13, 2026
Enalapril Maleate Tablets recall
Why: Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.
- Lots / codes
Lot #: GEH25023, Expires: 6/30/2027
- Quantity
- 675 bottles
- Company
- JB Chemicals and Pharmaceuticals Ltd, Mumbai
- Distribution
- Nationwide in the USA
- Initiated
- April 23, 2026 · Voluntary: Firm initiated
- Classified
- May 5, 2026
- Reported
- May 13, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Enalapril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.